David Severs

668 total citations
24 papers, 361 citations indexed

About

David Severs is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Severs has authored 24 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Severs's work include Dialysis and Renal Disease Management (8 papers), Sodium Intake and Health (4 papers) and Renal function and acid-base balance (4 papers). David Severs is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Sodium Intake and Health (4 papers) and Renal function and acid-base balance (4 papers). David Severs collaborates with scholars based in Netherlands, United States and Germany. David Severs's co-authors include Ewout J. Hoorn, Maarten B. Rookmaaker, A.H. Jan Danser, M.W.M. Wassenberg, Marc J. M. Bonten, Robert Zietse, Lajos Markó, Dominik N. Müller, Stephanie Lankhorst and Anton H. van den Meiracker and has published in prestigious journals such as Hypertension, Cardiovascular Research and Nutrients.

In The Last Decade

David Severs

21 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Severs Netherlands 11 109 99 98 57 56 24 361
Arnaldo Lopez‐Ruiz United States 11 103 0.9× 67 0.7× 31 0.3× 36 0.6× 93 1.7× 25 429
Marcelo R. Choi Argentina 12 167 1.5× 163 1.6× 90 0.9× 55 1.0× 84 1.5× 45 458
Brian Penner Canada 9 73 0.7× 81 0.8× 93 0.9× 18 0.3× 38 0.7× 14 293
Anna C. van der Burgh Netherlands 11 59 0.5× 42 0.4× 59 0.6× 18 0.3× 34 0.6× 19 333
Chulin Huang China 11 51 0.5× 73 0.7× 55 0.6× 16 0.3× 60 1.1× 32 399
John Molvin Sweden 11 33 0.3× 133 1.3× 57 0.6× 16 0.3× 28 0.5× 23 284
Philipp Schütz Switzerland 9 68 0.6× 28 0.3× 22 0.2× 52 0.9× 75 1.3× 30 315
Eirini Grapsa Greece 11 30 0.3× 35 0.4× 141 1.4× 40 0.7× 32 0.6× 30 372
Min‐Hsiang Chuang Taiwan 12 39 0.4× 22 0.2× 43 0.4× 44 0.8× 60 1.1× 70 429
Hiroki Nishiwaki Japan 11 40 0.4× 23 0.2× 69 0.7× 27 0.5× 33 0.6× 64 301

Countries citing papers authored by David Severs

Since Specialization
Citations

This map shows the geographic impact of David Severs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Severs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Severs more than expected).

Fields of papers citing papers by David Severs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Severs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Severs. The network helps show where David Severs may publish in the future.

Co-authorship network of co-authors of David Severs

This figure shows the co-authorship network connecting the top 25 collaborators of David Severs. A scholar is included among the top collaborators of David Severs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Severs. David Severs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franssen, Casper, Eiske M. Dorresteijn, Nicole C. A. J. van de Kar, et al.. (2025). Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. Nephrology Dialysis Transplantation. 40(10). 1887–1896. 2 indexed citations
2.
Laging, Mirjam, Sara J. Baart, Michel J. Vos, et al.. (2025). Dietary intake of oxalic acid affects plasma oxalic acid concentration in patients with kidney failure. Clinical Nutrition ESPEN. 67. 303–310.
4.
Laging, Mirjam, Sara J. Baart, Dennis A. Hesselink, et al.. (2024). Delayed Graft Function After Kidney Transplantation: The Role of Residual Diuresis and Waste Products, as Oxalic Acid and Its Precursors. Transplant International. 37. 13218–13218. 2 indexed citations
5.
Weerd, Annelies E. de, Dave L. Roelen, Michiel G.H. Betjes, et al.. (2024). Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series. Transplantation Direct. 10(9). e1695–e1695. 1 indexed citations
6.
Severs, David, et al.. (2023). Measuring body composition in hemodialysis patients: before or after hemodialysis?. Clinical Nutrition Open Science. 51. 62–66.
7.
Oudman, Erik, et al.. (2023). Wernicke's Encephalopathy in Acute and Chronic Kidney Disease: A Systematic Review. Journal of Renal Nutrition. 34(2). 105–114. 2 indexed citations
8.
Burgh, Anna C. van der, et al.. (2023). Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta‐analysis. Journal of Cachexia Sarcopenia and Muscle. 14(6). 2498–2508. 11 indexed citations
9.
Costello, Hannah M., David Severs, Alicja Czopek, et al.. (2022). High salt intake activates the hypothalamic–pituitary–adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice. Cardiovascular Research. 119(8). 1740–1750. 13 indexed citations
10.
Blijdorp, Charles J., Thomas A. Hartjes, Dominique M. Bovée, et al.. (2022). Nephron mass determines the excretion rate of urinary extracellular vesicles. Journal of Extracellular Vesicles. 11(1). e12181–e12181. 42 indexed citations
11.
Severs, David, et al.. (2022). Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients. European Journal of Clinical Pharmacology. 78(8). 1273–1287. 10 indexed citations
12.
Bovée, Dominique M., Estrellita Uijl, David Severs, et al.. (2021). Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. American Journal of Physiology-Renal Physiology. 320(4). F654–F668. 10 indexed citations
13.
Blijdorp, Charles J., David Severs, Ronald T. Gansevoort, et al.. (2020). Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 36(12). 2248–2255. 13 indexed citations
14.
Severs, David, Koen Verdonk, Nils van der Lubbe, et al.. (2018). Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone. Frontiers in Physiology. 9. 578–578. 14 indexed citations
15.
Lankhorst, Stephanie, David Severs, Lajos Markó, et al.. (2017). Salt Sensitivity of Angiogenesis Inhibition–Induced Blood Pressure Rise. Hypertension. 69(5). 919–926. 38 indexed citations
16.
Thiel, Bibi S. van, Luuk te Riet, David Severs, et al.. (2017). Brain Renin–Angiotensin System. Hypertension. 69(6). 1136–1144. 73 indexed citations
17.
Severs, David, Maarten B. Rookmaaker, & Ewout J. Hoorn. (2015). Intravenous Solutions in the Care of Patients With Volume Depletion and Electrolyte Abnormalities. American Journal of Kidney Diseases. 66(1). 147–153. 8 indexed citations
18.
Lankhorst, Stephanie, David Severs, Lajos Markó, et al.. (2015). 6B.05. Journal of Hypertension. 33(Supplement 1). e77–e77. 2 indexed citations
19.
Severs, David, Ewout J. Hoorn, & Maarten B. Rookmaaker. (2014). A critical appraisal of intravenous fluids: from the physiological basis to clinical evidence. Nephrology Dialysis Transplantation. 30(2). 178–187. 51 indexed citations
20.
Wassenberg, M.W.M., David Severs, & Marc J. M. Bonten. (2010). Psychological impact of short-term isolation measures in hospitalised patients. Journal of Hospital Infection. 75(2). 124–127. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026